Epilepsy and Behavior

Diagnostic delay in functional seizures is associated with abnormal processing of facial emotions.  131. 2022

A feasibility study to assess social stress and social support in patients enrolled in a cannabidiol (CBD) compassionate access program.  124. 2021

Cannabidiol (CBD) and cognition in epilepsy.  124. 2021

Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy.  122. 2021

Relationships between cognitive function, seizure control, and self-reported leisure-time exercise in epilepsy.  118. 2021

Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy.  117. 2021

Coffee and cigarette smoking interactions with lamotrigine.  116. 2021

Response to Letter to the Editor “Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?”.  113. 2020

Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy.  112. 2020

Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsy.  112. 2020

What's in a name?.  112. 2020

What's in a name?.  112:107364. 2020

Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.  111. 2020

Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.  109. 2020

Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity.  109. 2020

Poverty, insurance, and region as predictors of epilepsy treatment among US adults.  107. 2020

Changes in description naming for common and proper nouns after left anterior temporal lobectomy.  106. 2020

Language predictors of autism spectrum disorder in young children with tuberous sclerosis complex.  103. 2020

Neuroimaging of memory in frontal lobe epilepsy.  103. 2020

Optimizing therapies for neurobehavioral comorbidities of epilepsy using chronic ambulatory electrocorticography.  102. 2020

Racial differences in adult-onset MRI-negative temporal lobe epilepsy.  100. 2019

Health literacy and quality of life in patients with treatment-resistant epilepsy.  99. 2019

Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.  98:201-206. 2019

Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy.  97:105-110. 2019

A pilot study of combined endurance and resistance exercise rehabilitation for verbal memory and functional connectivity improvement in epilepsy.  96:44-56. 2019

fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.  96:114-121. 2019

Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.  95:131-136. 2019

Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.  95:10-17. 2019

Cortical excitability affects mood state in patients with idiopathic generalized epilepsies (IGEs).  90:84-89. 2019

Cortical excitability and seizure control influence attention performance in patients with idiopathic generalized epilepsies (IGEs).  89:135-142. 2018

Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.  87:131-136. 2018

Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.  86:131-137. 2018

Affiliate stigma and caregiver burden in intractable epilepsy.  85:1-6. 2018

Facial emotion processing in patients with seizure disorders.  79:193-204. 2018

The clinical impact of integration of magnetoencephalography in the presurgical workup for refractory nonlesional epilepsy.  79:34-41. 2018

Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver Hoef.  (in press). 2018

Orbitofrontal epilepsy: Case series and review of literature.  76:32-38. 2017

Post-traumatic epilepsy associations with mental health outcomes in the first two years after moderate to severe TBI: A TBI Model Systems analysis.  73:240-246. 2017

Precuneal epilepsy: Clinical features and surgical outcome.  73:77-82. 2017

Increased odds and predictive rates of MMPI-2-RF scale elevations in patients with psychogenic non-epileptic seizures and observed sex differences..  72:43-50. 2017

Cannabinoids and epilepsy — Introduction.  70:277. 2017

Influence of seizures on early development in tuberous sclerosis complex..  70:245-252. 2017

Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.  70:349-354. 2017

Pharmacology of cannabinoids in the treatment of epilepsy.  70:313-318. 2017

Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly.  70:253-258. 2017

Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.  70:364-369. 2017

Social factors in marijuana use for medical and recreational purposes.  70:280-287. 2017

Caregiver-reported religious beliefs and complementary and alternative medicine use among children admitted to an epilepsy monitoring unit.  69:139-146. 2017

Photosensitivity in generalized epilepsies.  68:225-233. 2017

Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare.  66:68-73. 2017

Which patients with epilepsy are at risk for psychogenic nonepileptic seizures (PNES)? A multicenter case–control study.  61:180-184. 2016

Parent health literacy and adherence-related outcomes in children with epilepsy.  56:73-82. 2016

Assessment of driving outcomes after epilepsy surgery.  52:25-30. 2015

Personalities of patients with nonepileptic psychogenic status.  52:143-148. 2015

New-onset refractory status epilepticus (NORSE) - The potential role for immunotherapy.  47:17-23. 2015

The effect of medial temporal lobe epilepsy on visual memory encoding.  46:173-184. 2015

Uncinate fasciculus connectivity in patients with psychogenic nonepileptic seizures: A preliminary diffusion tensor tractography study.  45:68-73. 2015

Cannabis, cannabidiol, and epilepsy - From receptors to clinical response.  41:277-282. 2014

Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy: Response to a biochemical evaluation.  41:312-313. 2014

Social determinants of health in epilepsy.  41:283-289. 2014

Celebrating 15years of Epilepsy & Behavior and to the next 15years!.  40:77. 2014

Functional MRI of facial emotion processing in left temporal lobe epilepsy.  32:92-99. 2014

Contributions of fMRI towards our understanding of the response to psychosocial stress in epilepsy and psychogenic nonepileptic seizures.  35:19-25. 2014

Different localizations underlying cortical gelastic epilepsy: Case series and review of literature.  35:34-41. 2014

EEG/fMRI contributions to our understanding of genetic generalized epilepsies.  34:129-135. 2014

How focal is generalized epilepsy: A distinction with a difference?.  34:127-128. 2014

Physiologic and cortical response to acute psychosocial stress in left temporal lobe epilepsy - A pilot cross-sectional fMRI study.  36:115-123. 2014

Art and epilepsy surgery.  29:82-89. 2013

The effects of temporal lobe epilepsy on scene encoding.  26:11-21. 2013

Differential effects of antiepileptic drugs on neonatal outcomes.  24:449-456. 2012

Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy.  24:74-80. 2012

Systematic review and case series of neuropsychological functioning after epilepsy surgery in children with dysembryoplastic neuroepithelial tumors (DNET).  23:481-486. 2012

Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention.  23:280-284. 2012

Geriatric epilepsy: Research and clinical directions for the future.  22:103-111. 2011

Corrigendum to "Planning extent of resection in epilepsy: Limited versus large resections" [Epilepsy & Behavior 20, Issue 2 (2011) 233-240].  21:494. 2011

Semantic association investigated with functional MRI and independent component analysis.  20:613-622. 2011

The effects of left or right hemispheric epilepsy on language networks investigated with semantic decision fMRI task and independent component analysis.  20:623-632. 2011

Planning extent of resection in epilepsy: Limited versus large resections.  20:233-240. 2011

Nonepileptic psychogenic status: Markedly prolonged psychogenic nonepileptic seizures.  19:65-68. 2010

Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI.  18:404-413. 2010

Moderating effect of optimism on emotional distress and seizure control in adults with temporal lobe epilepsy.  18:374-380. 2010

Passive real-time identification of speech and motor cortex during an awake craniotomy.  18:123-128. 2010

Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.  17:525-530. 2010

The effect of seizures on working memory and executive functioning performance.  17:412-419. 2010

Recognition of child abuse in the epilepsy monitoring unit.  17:296-297. 2010

Application of signal detection theory to verbal memory testing to distinguish patients with psychogenic nonepileptic seizures from patients with epileptic seizures.  14:597-603. 2009

Compensatory brain activation for recognition memory in patients with medication-resistant epilepsy.  13:463-469. 2008

Optimism, pessimism, and neuropsychological performance across semiology-based subtypes of psychogenic nonepileptic seizures.  13:478-484. 2008

The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.  13:376-380. 2008

Rey Osterrieth complex figure test spatial and figural scoring: Relations to seizure focus and hippocampal pathology in patients with temporal lobe epilepsy.  13:174-177. 2008

The use of self-generation procedures facilitates verbal memory in individuals with seizure disorders.  13:162-168. 2008

Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy.  12:410-418. 2008

Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua.  12:332-336. 2008

Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy.  12:74-83. 2008

A psychosocial self-management program for epilepsy: A randomized pilot study in adults.  11:533-545. 2007

Relationship between semiology of psychogenic nonepileptic seizures and Minnesota Multiphasic Personality Inventory profile.  11:105-111. 2007

Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy.  10:242-249. 2007

A comparison of physicians' attitudes and beliefs regarding driving for persons with epilepsy.  10:55-62. 2007

Medical decision-making abilities in older adults with chronic partial epilepsy.  10:63-68. 2007

The effects of duration of intractable epilepsy on memory function.  9:469-477. 2006

Racial/ethnic disparities in the treatment of epilepsy: What do we know? What do we need to know?.  9:243-264. 2006

Nonepileptic seizures treatment workshop summary.  8:451-461. 2006

Quality of life in medication-resistant epilepsy: The effects of patient's age, age at seizure onset, and disease duration.  8:547-551. 2006

Determining empirically based self-reported cognitive change: Development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample.  8:239-245. 2006

Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment.  8:161-168. 2006

Development of reliable change indices and standardized regression-based change norms for the Multiple Abilities Self-report Questionnaire (MASQ) in an epilepsy sample.  8:239-245. 2006

Race/ethnicity: A predictor of temporal lobe epilepsy surgery outcome?.  7:486-490. 2005

Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II.  7:266-272. 2005

Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II..  7:266-272. 2005

What are the concerns of older adults living with epilepsy?.  7:297-300. 2005

What are the concerns of older adults living with epilepsy?.  7:297-300. 2005

Verbal memory outcome in patients with normal preoperative verbal memory and left mesial temporal sclerosis.  6:337-341. 2005

Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy.  5:1024-1026. 2004

Reporting race/ethnicity in epilepsy clinical trials.  5:743-745. 2004

Self-report of cognitive abilities in temporal lobe epilepsy: Cognitive, psychosocial, and emotional factors.  5:575-579. 2004

Taking charge of epilepsy: The development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents.  5:547-556. 2004

Seizure disorders, depression, and health-related quality of life.  5:50-57. 2004

Accuracy of self-reported neuropsychological functioning in individuals with epileptic or psychogenic nonepileptic seizures.  5:143-150. 2004

High-resolution functional MRI at 3 T in healthy and epilepsy subjects: Hippocampal activation with picture encoding task.  5:244-252. 2004

Health-related quality of life in senior adults with epilepsy: What we know from randomized clinical trials and suggestions for future research.  4:626-634. 2003

Ketamine for refractory status epilepticus : A case of possible ketamine-induced neurotoxicity.  4:70-75. 2003

Does the wada test predict memory decline following epilepsy surgery?.  3:4-15. 2002

Gender, memory, and hippocampal volumes: Relationships in temporal lobe epilepsy.  1:112-119. 2000

Nonlinear trends in hippocampal metabolic function and verbal memory: Evidence of cognitive reserve in temporal lobe epilepsy?.  1:106-111. 2000